In addition, the Ras/Raf/MEK/MAPK-ERK pathway was also linked to PD-L1 overexpression in various cancers, while respective inhibitors lead to a downregulation of PD-L1 expression [86,87]. This evidence concerns the gene CD274 and cancer.